Discovery and pre-clinical evaluation of antibodies to the NKG2A inhibitory receptor | bioRxiv
HLA-E and NKG2A as a novel immune checkpoint axis to improve treatment for non-muscle invasive bladder cancer | Horowitz Laboratory
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells - ScienceDirect
NKG2A blockade releases the brakes on CD8+ T cells and NK cells
![Recombinant Anti-NKG2A antibody [EPR23737-127] (ab260035) | Abcam](https://www.abcam.com/ps/products/260/ab260035/Images/ab260035-450307-AntiNKG2A-antibody-Immunohistochemistry.jpg "Recombinant Anti-NKG2A antibody [EPR23737-127] (ab260035) | Abcam")
Recombinant Anti-NKG2A antibody [EPR23737-127] (ab260035) | Abcam
JCI - Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells
Frontiers | The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy
Downregulation of NKG2A expression in NK cells with anti-NKG2A PEBLs.... | Download Scientific Diagram
Blocking the Natural Killer Cell Inhibitory Receptor NKG2A Increases Activity of Human Natural Killer Cells and Clears Hepatitis B Virus Infection in Mice - Gastroenterology
NKG2A is a NK cell exhaustion checkpoint for HCV persistence | Nature Communications
CD94/NKG2A þ HLA-A2-restricted antigen-specific T cells have impaired... | Download Scientific Diagram
A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells | PLOS Pathogens
JCI - Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells
Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment | Journal for ImmunoTherapy of Cancer | Full Text
Frontiers | Tuning Natural Killer Cell Anti-multiple Myeloma Reactivity by Targeting Inhibitory Signaling via KIR and NKG2A
JCI - Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells
JCI - Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells
Frontiers | NK Cell Dysfunction and Checkpoint Immunotherapy
NKG2A/CD159a/KLRC1 Antibody (NBP2-17084): Novus Biologicals
NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy | Signal Transduction and Targeted Therapy
NKG2A is a NK cell exhaustion checkpoint for HCV persistence | Nature Communications
NKG2A, a New Kid on the Immune Checkpoint Block - ScienceDirect
Next-IO™ Anti-CD94/NKG2A Monoclonal Antibody Program - Creative Biolabs
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer - ScienceDirect
![NKG2A/CD159a/KLRC1 Antibody (131411) [Unconjugated] (MAB1059): Novus Biologicals](https://images.novusbio.com/fullsize2/NKG2A_MAB1059_Flow_Cytometry_21858.jpg "NKG2A/CD159a/KLRC1 Antibody (131411) [Unconjugated] (MAB1059): Novus Biologicals")
NKG2A/CD159a/KLRC1 Antibody (131411) [Unconjugated] (MAB1059): Novus Biologicals
Higher-Order Structure Characterization of NKG2A/CD94 Protein Complex and Anti-NKG2A Antibody Binding Epitopes by Mass Spectrometry-Based Protein Footprinting Strategies | Journal of the American Society for Mass Spectrometry
Vaccines | Free Full-Text | Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer
Monalizumab: inhibiting the novel immune checkpoint NKG2A | Journal for ImmunoTherapy of Cancer | Full Text
Frontiers | Implications of NKG2A in immunity and immune-mediated diseases
